This pioneering study defined DHODH as a metabolic regulator of differentiation in multiple subtypes of acute myeloid leukemia (AML) and DHODH inhibition emerged as a potential strategy for overcoming differentiation blockade in treating AML (135). The gene discussed is DHODH; the disease is acute myeloid leukemia.